Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20251118068036N3Phase 3Recruiting
Phase 3 trial of melatonin in Insomnia and anxiety disorder (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Sleep quality before surgery and Preoperative anxiety. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20251118068036N3.